Arch Cancer Therapeutics Ltd

Permanently closed
Call
Website

Advertisement

27 St Clair Ave E
Toronto, ON M4T 1L8

Arch Cancer Therapeutics Ltd, also known as Arch Biopartners, is a therapeutic biotech company based in Toronto, focused on developing innovative on-target drugs for acute kidney injury (AKI) and chronic kidney disease (CKD). With lead drug candidates LSALT peptide and Cilastatin currently in Phase II clinical trials, the company aims to address serious conditions affecting millions of patients globally.

Arch's CKD platform targets IL-32, a cytokine linked to diabetic kidney disease, which is the leading cause of kidney failure worldwide. By advancing therapeutic options for both acute and chronic kidney diseases, Arch Biopartners is positioned to make a significant impact in the field where effective treatments are currently limited.

Generated from the website

Own this business?
See a problem?

You might also like

CanadaOntarioTorontoArch Cancer Therapeutics Ltd

Partial Data by Infogroup (c) 2025. All rights reserved.

Advertisement